Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Brian Firestone"'
Autor:
Amy C Schefler, Alison Skalet, Scott C N Oliver, John Mason, Anthony B Daniels, Katherina M Alsina, Kristen M Plasseraud, Federico A Monzon, Brian Firestone
Publikováno v:
Melanoma Management, Vol 7, Iss 1 (2020)
Aim: The Clinical Application of DecisionDx-UM Gene Expression Assay Results study aimed to evaluate the clinical utility of the prognostic 15-gene expression profile (15-GEP) test for uveal melanoma (UM) patients in a large, prospective multicenter
Externí odkaz:
https://doaj.org/article/caa0764e62ad4c85944236eca8cb71a4
Autor:
Zachary Richards, My-Lien Nguyen, Michael Kutteh, Salahuddin Ahmad, Christina Henson, Brian Firestone, Terence S. Herman, Tania De La Fuente Herman
Publikováno v:
Medical Dosimetry. 47:273-279
The aim of our study is to document our cases of choroidal melanoma treated with low dose rate (LDR) brachytherapy and to correlate the dosimetry and radiobiology with clinical effects and oncologic outcomes. Data from 157 patients treated from 2014
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66cd966ad46a84753d91f2e81c8bfe47
https://doi.org/10.1016/j.meddos.2022.04.006
https://doi.org/10.1016/j.meddos.2022.04.006
Autor:
T Herman, Salahuddin Ahmad, Brian Firestone, Christina Henson, Leland Muller, Terence S. Herman
Publikováno v:
Medical dosimetry : official journal of the American Association of Medical Dosimetrists. 44(3)
The primary occurrence of mucoepidermoid carcinoma (MEC) of the conjunctiva is extremely rare, aggressive, and easily mistaken for squamous cell carcinoma. With fewer than 50 cases reported in the literature, there is no consensus on the most effecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6cfbe2706e1ea6230b606647b0d5e1d
https://pubmed.ncbi.nlm.nih.gov/30366619
https://pubmed.ncbi.nlm.nih.gov/30366619
Publikováno v:
AIP Conference Proceedings.
Eye malignancies that are suitable candidates for low dose-rate brachytherapy have been treated using the Collaborative Ocular Melanoma Study (COMS) eye plaques with radioactive I-125 seeds at the University of Oklahoma Medical Center (OUMC). Partial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::475c71e375d62f1020eafabfeef7d7c5
https://doi.org/10.1063/1.4954089
https://doi.org/10.1063/1.4954089
Publikováno v:
Retinoblastoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89f927db5ba1ed614586ac12a51680b7
https://doi.org/10.5005/jp/books/11629_17
https://doi.org/10.5005/jp/books/11629_17
Autor:
Brian, Firestone, James W, Mold
Publikováno v:
The Journal of family practice. 58(6)
Benefits of interventions are usually reported as relative risk reductions. Absolute risk reductions (ARRs)-most relevant to individual patients-are reported less often.Estimate ARRs for interventions in a patient with diabetes mellitus.We used the A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c8573f99fdd5f537a9214872488074a7
https://pubmed.ncbi.nlm.nih.gov/19508839
https://pubmed.ncbi.nlm.nih.gov/19508839
Autor:
Chance Matthiesen, D Johnson, Brian Firestone, T De La Fuente Herman, Clara Ferreira, Salahuddin Ahmad
Publikováno v:
Medical Physics. 42:3486-3486
Purpose: To compare dosimetrically three plan calculation systems (Plato, Varian Brachytherapy, and in-house-made Excel) available for I-125 COMS eye plaque treatment with measurement. Methods: All systems assume homogeneous media and calculations ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::96db448b2a931fdbba5bd0210a17b465
https://doi.org/10.1118/1.4925015
https://doi.org/10.1118/1.4925015